Affirmed Pharma LLC Profile last edited on: 3/23/2023
CAGE: 8K4Q2
UEI: H7EZXRR3HKB7
Business Identifier: Late stage development drugs to high value therapeutics. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 02
County: Montgomery
Congr. District: 02
County: Montgomery
Public Profile
Affirmed Pharma, LLC organizes around three areas of cosus: Regenerative Medicine: target inghigh value therapeutics that harness body's natural regenerative pathways to reduce harmful inflammation and promote tissue regeneration. Cancer Immunotherapies: target therapies to stimulate the patient's immune system, activating body's natural defense mechanisms to fight malignancies and to protect normal cells. and Cardiovascular Disease: targeting interventions in myocardial regeneration including endogenous modulators of stem cells and angiogenic factors.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 1 | NIH | $341,302 | |
| Project Title: Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy | ||||
| 2022 | 1 | NIH | $450,036 | |
| Project Title: Rusalatide Acetate (TP508) Mitigation of Genotoxic Radiation Damage in Human Lens Epithelial Cells | ||||
Key People / Management
Usha P Andley
Steven J Frank
Jane L Hicks -- Co-Founder. Strategic Planning, Business Development and Commercialization Lead
Philip Swain -- Medicinal Chemistry Team Lead
John K Weatherspoon -- Co-Founder
Steven J Frank
Jane L Hicks -- Co-Founder. Strategic Planning, Business Development and Commercialization Lead
Philip Swain -- Medicinal Chemistry Team Lead
John K Weatherspoon -- Co-Founder
Company News
There are no news available.
